Table: Zeria Pharm -Q1 group results

Zeria Pharmaceutical

03/08/2023 08:00

Aug 3 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             18.30               16.31            73.00    
                 (+12.3 pct)         (+20.3 pct)      (+6.8 pct)  
  Operating          2.97                2.98             9.10    
                 (-0.2 pct)         (+137.8 pct)      (+0.9 pct)  
  Recurring          3.36                2.97             9.00    
                 (+12.8 pct)         (+42.9 pct)      (+18.7 pct) 
  Net                2.92                2.60             7.00    
                 (+12.1 pct)         (+84.6 pct)      (+13.0 pct) 
  EPS             66.14 yen           58.71 yen       158.80 yen  
  Ann Div                             40.00 yen        44.00 yen  
  -Q2 div                             18.00 yen        22.00 yen  
  -Q4 div                             22.00 yen        22.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T